16.02.2015 Views

JSB Market Research : Biopharma M&A and Deal Making - Understanding the Latest Trends to Optimize Future Strategy

The report, Biopharma M&A and Deal Making - Understanding the Latest Trends to Optimize Future Strategy, was written to support team and corporate strategic initiatives around the options that exist to grow revenues through externalization, whether by M&A or licensing.The leading pharmaceutical players continue to face the combined threats of a difficult operating environment and patent losses while struggling to deliver on pipeline potential. See Full Report : http://bit.ly/1L29teX

The report, Biopharma M&A and Deal Making - Understanding the Latest Trends to Optimize Future Strategy, was written to support team and corporate strategic initiatives around the options that exist to grow revenues through externalization, whether by M&A or licensing.The leading pharmaceutical players continue to face the combined threats of a difficult operating environment and patent losses while struggling to deliver on pipeline potential.

See Full Report : http://bit.ly/1L29teX

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Biopharma</strong> M&A <strong>and</strong> <strong>Deal</strong> <strong>Making</strong> - Underst<strong>and</strong>ing <strong>the</strong> <strong>Latest</strong><br />

<strong>Trends</strong> <strong>to</strong> <strong>Optimize</strong> <strong>Future</strong> <strong>Strategy</strong><br />

Released On 16 th February 2015<br />

The leading pharmaceutical players continue <strong>to</strong> face <strong>the</strong> combined threats of a difficult operating<br />

environment <strong>and</strong> patent losses while struggling <strong>to</strong> deliver on pipeline potential. Externalization<br />

strategies are a key means <strong>to</strong> boost future revenues <strong>and</strong>, indeed more imminently, <strong>to</strong> satisfy<br />

shareholder dem<strong>and</strong>s. However, <strong>the</strong> increasing size of <strong>the</strong> leading biopharmaceutical companies<br />

is necessitating <strong>the</strong>ir involvement in growing <strong>the</strong> numbers <strong>and</strong> size of deals year by year. This in<br />

itself, along with <strong>the</strong> rising financial firepower of <strong>the</strong> mid-tier players, has increased <strong>the</strong> level of<br />

competition for <strong>the</strong> most attractive targets.<br />

Increased competition in <strong>the</strong> marketplace for M&A <strong>and</strong> licensing deals can artificially inflate <strong>the</strong><br />

cost of <strong>the</strong>se deals, dis<strong>to</strong>rting <strong>the</strong> balance of value, risk <strong>and</strong> return. As a result companies must<br />

employ more rigorous selection processes <strong>and</strong> exp<strong>and</strong> search criteria <strong>to</strong> consider more diverse<br />

options if <strong>the</strong>y are <strong>to</strong> maximize <strong>the</strong>ir returns on investment.<br />

The report, <strong>Biopharma</strong> M&A <strong>and</strong> <strong>Deal</strong> <strong>Making</strong> - Underst<strong>and</strong>ing <strong>the</strong> <strong>Latest</strong> <strong>Trends</strong> <strong>to</strong> <strong>Optimize</strong><br />

<strong>Future</strong> <strong>Strategy</strong>, was written <strong>to</strong> support team <strong>and</strong> corporate strategic initiatives around <strong>the</strong> options<br />

that exist <strong>to</strong> grow revenues through externalization, whe<strong>the</strong>r by M&A or licensing. CBR Pharma<br />

Insights provides in-depth analysis on <strong>the</strong> deals being done <strong>to</strong>day, <strong>the</strong> trends being seen over<br />

time, <strong>and</strong> <strong>the</strong> strategies employed throughout <strong>the</strong> industry.<br />

<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />

Email ID- contact@jsbmarketresearch.com<br />

Tel No- 91 2241236650 / +91 - 998 729 5242<br />

Published by- http:/www.jsbmarketresearch.com/


Scope<br />

<strong>Trends</strong> in recent deal activity<br />

Successful deal making<br />

<strong>Future</strong> deal activity<br />

Key Reasons <strong>to</strong> Purchase<br />

Underst<strong>and</strong> <strong>and</strong> evaluate <strong>the</strong> strategies being used by companies of all sizes <strong>to</strong> support future<br />

revenue growth<br />

Benefit from CBRs case study analysis of <strong>the</strong> different types of deals being done in <strong>the</strong> current &<br />

future biopharma industry<br />

Access data <strong>and</strong> trends analysis of <strong>the</strong> types of deals taking place <strong>and</strong> which <strong>the</strong>rapeutic areas are<br />

showing <strong>the</strong> most activity<br />

Gain insights around <strong>the</strong> steps that need <strong>to</strong> be taken in order <strong>to</strong> best secure a successful deal<br />

Learn who <strong>the</strong> key companies are <strong>to</strong> watch for in <strong>the</strong> coming year, <strong>the</strong> motivations behind <strong>the</strong><br />

deals <strong>the</strong>y are doing, <strong>and</strong> identify which ones relate <strong>to</strong> your business strategies<br />

Browse complete Report on:<br />

http://www.jsbmarketresearch.com/healthcare-medical/r-<strong>Biopharma</strong>-MA-<strong>Deal</strong>-<br />

<strong>Making</strong>-Underst<strong>and</strong>ing-25040<br />

Table of Contents<br />

Executive Summary<br />

Chapter 1: Introduction<br />

What is driving <strong>the</strong> increased use of externalization in biopharma industry strategies<br />

Externalization strategies: <strong>the</strong> options<br />

Benefits of different deal types from M&A <strong>to</strong> arms length licensing<br />

<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />

Email ID- contact@jsbmarketresearch.com<br />

Tel No- 91 2241236650 / +91 - 998 729 5242<br />

Published by- http:/www.jsbmarketresearch.com/


Chapter 2: <strong>Trends</strong> in recent deal activity<br />

M&A deal trends<br />

Key acquisitions in 2012 <strong>and</strong> <strong>the</strong> motives behind <strong>the</strong>m<br />

Most acquisitive companies<br />

Licensing deal trends (Type of deal, Therapy area, Phase)<br />

Divesting - <strong>the</strong> o<strong>the</strong>r extreme<br />

Focus on: <strong>Deal</strong> activity in <strong>the</strong> generics sec<strong>to</strong>r<br />

Chapter 3: Successful deal making<br />

Key steps <strong>to</strong> successful deal making<br />

Shift <strong>to</strong> earlier stage deals<br />

Differentiating capabilities <strong>to</strong> position company as "partner of choice“<br />

Focus on: Joint ventures in emerging markets<br />

Chapter 4: <strong>Future</strong> deal activity<br />

Key companies <strong>to</strong> watch in 2013<br />

Appendix<br />

Exclusive discounts on reports of your choice till 28th February,2015:<br />

http://www.jsbmarketresearch.com/discount.php<br />

Product Price :<br />

License Type<br />

Price<br />

PDF $ 3900<br />

Site Licence $ 4900<br />

Enterprise Wide Licence $ 9800<br />

<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />

Email ID- contact@jsbmarketresearch.com<br />

Tel No- 91 2241236650 / +91 - 998 729 5242<br />

Published by- http:/www.jsbmarketresearch.com/


Related reports:<br />

Electronic Health Records - Charting <strong>the</strong> <strong>Future</strong> of Health Care<br />

Reformulation Strategies - New Technologies Extend Use Beyond Lifecycle<br />

Management<br />

Looking at Senior Long-term Care - Where will <strong>the</strong> market go<br />

Risk Evaluation <strong>and</strong> Mitigation Strategies - Adaptation in an evolving system<br />

The Impact of Generics on Pharmaceutical Growth Opportunities - A growing<br />

threat that offers future opportunities<br />

Accelerating Drugs <strong>to</strong> <strong>Market</strong> - In Search of Opportunity Along <strong>the</strong> Drug<br />

Development & Approval Pathway<br />

New Product Launch Strategies - Initiating <strong>Market</strong> Entry with Sound Strategies<br />

<strong>and</strong> Tactics<br />

Pharmaceutical Sales Force Effectiveness - Rethinking <strong>the</strong> Current Sales Model<br />

Pharmaceutical Cliff Diving - Assessing <strong>the</strong> key challenges that will re-shape <strong>the</strong><br />

industry<br />

Healthcare <strong>and</strong> Medical <strong>Market</strong> <strong>Research</strong><br />

You can order this report by calling on +91 - 998 7295 242 or mail us your<br />

contact details at contact@jsbmarketresearch.com<br />

<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />

Email ID- contact@jsbmarketresearch.com<br />

Tel No- 91 2241236650 / +91 - 998 729 5242<br />

Published by- http:/www.jsbmarketresearch.com/


About <strong>JSB</strong> <strong>Market</strong> <strong>Research</strong>:-<br />

<strong>JSB</strong> market research is a leading player in <strong>the</strong> market of research report distribution. It is ones<strong>to</strong>p-shop<br />

for all information related <strong>to</strong> market research for any sec<strong>to</strong>r of <strong>the</strong> industry. Along with<br />

providing in-depth analysis though reports, <strong>JSB</strong> market research also provides regular updates of<br />

<strong>the</strong> market though newsletters. Our reports are a well-researched work of market researchers with<br />

an extensive knowledge <strong>and</strong> a good level of market experience.<br />

To know more on “<strong>Biopharma</strong> M&A <strong>and</strong> <strong>Deal</strong> <strong>Making</strong> - Underst<strong>and</strong>ing <strong>the</strong> <strong>Latest</strong><br />

<strong>Trends</strong> <strong>to</strong> <strong>Optimize</strong> <strong>Future</strong> <strong>Strategy</strong>”<br />

http://www.jsbmarketresearch.com/healthcare-medical/r-<strong>Biopharma</strong>-MA-<strong>Deal</strong>-<strong>Making</strong>-<br />

Underst<strong>and</strong>ing-25040<br />

<strong>JSB</strong> <strong>Market</strong> <strong>Research</strong> Pvt. Ltd.<br />

Email ID- contact@jsbmarketresearch.com<br />

Tel No- 91 2241236650 / +91 - 998 729 5242<br />

Published by- http:/www.jsbmarketresearch.com/

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!